Cancidas Related Clinical Trials
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia [Completed]
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation [Completed]
A Study to Evaluate 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults [Active, not recruiting]
Caspofungin for the Treatment of Non-Blood Candida Infections [Completed]
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants [Completed]
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients [Completed]
A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia [Completed]
Phase III Doubleblind, Comparative Study of MK0991 (Caspofungin) in Japanese Patients [Recruiting]
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia [Completed]
Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection [Recruiting]
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults [Recruiting]
Pharmacokinetics of Caspofungin in Burn Patients [Not yet recruiting]
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis [Recruiting]
COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis [Completed]
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units [Completed]
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis [Completed]
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings [Terminated]
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment [Active, not recruiting]
Prophylaxis With Caspofungin in High-Risk Liver Transplantation [Recruiting]
A Study of BAL8557 Versus Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections [Withdrawn]
Caspofungin Acetate in Treating Children With Fever and Neutropenia [Completed]
Randomized Study of Caspofungin Prophylaxis Followed by Pre-Emptive Therapy for Invasive Candidiasis in the ICU [Recruiting]
Documented Candida or Aspergillus Infections in Pediatric Patients [Completed]
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia [Completed]
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis [Completed]
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems [Recruiting]
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant [Recruiting]
Prophylaxis of Fungal Invasive Infections in Leukemia [Recruiting]
Isavuconazole in the Treatment of Candidemia and Other Invasive Candida Infections [Recruiting]
Antimicrobial PK in Infants With Suspected or Confirmed Infection [Recruiting]
Antifungal Use in Oncohematological Neutropenic Patients [Recruiting]
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole [Terminated]
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis [Completed]
Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants [Completed]
Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 [Terminated]
|
